P-2014. Online Clinician Education Curriculum Results in Performance Changes in Clinical Practice Related to Incorporating COVID-19 Antiviral Therapies for Non-Hospitalized Patients

Abstract Background This study examined whether online continuing medical education (CME/CE) focused on evidence-based best practices for incorporating COVID-19 antiviral therapies in non-hospitalized patients would result in improved identification of high-risk patient groups and the adoption of new clinical practices. Methods Clinicians who participated across a curriculum of 3, live and online, 30-minute CME/CE video discussions between experts. Performance was assessed by inviting learners to complete a survey 30-60 days post-education, identifying practice changes and the degree to which clinicians experience barriers to those changes. The data was collected from 11/29/2022 to 06/21/2023. Results There were 232 learners consisting of PCPs, Emergency Medicine Physicians, ID Specialists who completed the survey. The analyses from the 3 programs showed that approximately 98% of learners made a practice change or had practices reinforced due to education. Five key practice changes that were modified/implemented as a result of the education included:Identifying patients at higher risk for developing severe COVID-19-related complications (69%)Incorporating new information about treatment options for non-hospitalized patients with COVID-19 (67%)Ensure patients receive treatment within the appropriate therapeutic window (60%)Educating patients on COVID-19 and available antiviral treatments (58%)Screening patients for potential DDIs prior to COVID-19 antiviral initiation (55%)Some of the barriers to implementing these practice changes include:Patients present outside the recommended treatment windowUnfamiliar with potential drug-drug interactions for COVID-19 antiviralsPatient concerns or questions regarding available antiviralsUnfamiliar with guideline recommendations for available antiviralsLack of time during office visits to educate patients on the importance of timely testing and treatment Conclusion The practice changes identified in this assessment provide compelling evidence that participation in online CME/CE prompts adoption of changes in practice related to COVID-19 antiviral therapies in non-hospitalized patients. Acknowledgement: This education was supported by an independent educational grant from Pfizer Inc. and Merck & Co, Inc. Disclosures All Authors: No reported disclosures